Stifel Lowers Trupanion Price Target Amid Product Strategy Concerns

Price Target Adjustment#

Stifel has lowered its price target for Trupanion, Inc. (NASDAQ:TRUP) from $31 to $28 while maintaining a Hold rating on the stock. Currently, Trupanion shares are trading at $24.55, which is close to their 52-week low of $23.90.

Product Strategy Issues#

The firm has raised concerns about Trupanion's product strategy, stating that the company has recognized issues that should have been addressed over five years ago. Trupanion's main offering, a 90%-payout plan costing around $85 monthly or $1,000 annually, only appeals to a limited segment of the pet insurance market, especially as pet care costs continue to rise.

Market Share and Financial Performance#

Stifel highlighted that Trupanion has been losing market share consistently for the past seven years, which has led to a declining internal rate of return. This decline is attributed to increased spending without corresponding improvements in results. Over the last six months, Trupanion's stock has dropped by 40%, and the company's gross profit margin stands at 22.6%, indicating ongoing operational challenges. Stifel has been voicing these concerns for several years.

Future Outlook#

The analyst firm pointed out that Trupanion has not met several objectives outlined in its 2020 five-year plan, including initiatives like the Landspath project and the introduction of new insurance products. While a more diverse product portfolio could help the company, Stifel warns that the transition may not be quick or easy, given Trupanion's historical performance.

Recent Earnings Report#

In other news, Trupanion reported earnings for the first quarter of 2026 that exceeded expectations. The company achieved earnings per share (EPS) of $0.11, surpassing the forecast of $0.07, marking a 57.14% surprise. Additionally, Trupanion's revenue reached $384 million, exceeding the projected $379.7 million. Despite these positive results, BofA Securities lowered its price target for Trupanion from $59.00 to $52.00, citing concerns over profit margins while maintaining a Buy rating.